a16z Podcast | Mindsets for Engineering Biology

TL;DR

This podcast episode explores the intersection of science and engineering in the fields of medicine and biology, discussing the challenges and opportunities that arise when moving across disciplines.

Transcript

hi everyone welcome to the a 16z podcast I'm Hana and today's episode continues our ongoing series on how science becomes engineering and all the new challenges and opportunities that presents as people move across fields and into new mindsets it's a conversation between a 16-0 partner Vijay Pandey who heads up our bio Fund and Bob Langer Institute... Read More

Key Insights

• 💗 Traditional approaches in medicine involved using unconventional materials and off-the-shelf products, but there is a growing focus on engineering and synthesizing optimal biomaterials.
• 🚚 The ability to engineer drug delivery systems and target specific areas of the body can greatly improve the safety and efficacy of treatments.
• 🚄 High throughput methods and technologies, like robotics and machine learning, have increased the speed and efficiency of research and development in the field.
• 😷 Balancing safety and innovation is a challenge in the regulation of new medical treatments, with pivotal moments like the AIDS epidemic and the Vioxx situation shaping FDA policies.
• 💊 The future of healthcare may involve a shift towards personalized medicines, genetic therapies, regenerative medicine, and the ability to create tissues and organs in vitro.
• 🎁 The intersection of science and engineering presents both challenges and opportunities in the fields of medicine and biology, and a mindset shift towards a more engineering-focused approach is occurring.

Questions & Answers

Q: How have materials been incorporated into medicine in unconventional ways?

Clinicians have used everyday objects, such as ladies' girdles and mattress stuffing, to mimic organs and tissues for medical purposes.

Q: How have controlled-release polymer systems revolutionized drug delivery?

These systems allow for the slow release of large molecules, such as peptides and proteins, over an extended period, enabling the treatment of conditions like advanced prostate cancer and diabetes.

Q: What are the potential benefits of DNA and RNA drugs in medicine?

DNA therapy and gene editing could provide solutions for enzyme deficiency diseases, while RNA drugs like siRNA can stop the production of certain proteins that contribute to medical issues.

Q: How has the field of biopharma evolved over time?

There has been a shift towards protein drugs, with advancements in genetic engineering allowing for the creation of therapeutic proteins. Additionally, research is underway for DNA and RNA drugs that could revolutionize treatment approaches.

Summary & Key Takeaways

• Materials have found their way into medicine through unconventional methods, such as using a ladies' girdle material to create an artificial heart.

• Advances in controlled-release polymer systems have revolutionized drug delivery, allowing for the treatment of various diseases and conditions.

• The field of biopharma is evolving, with a shift towards protein drugs and the potential for DNA and RNA drugs to have a transformative impact.